CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor

Circulating tumor cells (CTCs) and/or circulating tumor microemboli (CTM) from non-small cell lung cancer (NSCLC) patients may be a non-invasive tool for prognosis, acting as liquid biopsy. CTCs interact with platelets through the transforming growth factor-β/transforming growth factor-β receptor ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Torres, Jacqueline Aparecida, Brito, Angelo Borsarelli Carvalho, Silva, Virgilio Souza e, Messias, Iara Monique, Braun, Alexcia Camila, Ruano, Anna Paula Carreta, Buim, Marcilei E. C., Carraro, Dirce Maria, Chinen, Ludmilla Thomé Domingos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419161/
https://www.ncbi.nlm.nih.gov/pubmed/37569332
http://dx.doi.org/10.3390/ijms241511958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419161/
https://www.ncbi.nlm.nih.gov/pubmed/37569332
http://dx.doi.org/10.3390/ijms241511958

Ejemplares similares